secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2026-09-08T21:12:57+00:00
Accession:  0001104659-26-105953
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics enters $477.6M ASR to complete $2B buyback authorization
----------------------------------------------------------------------------

- Entered ASR with Citibank to repurchase ~$477.6M stock; upfront payment ~Sept 10, 2026.
- Initial delivery ~719,376 shares (75% of anticipated total based on 9/8/26 close); final settlement Q4 2026.
- Prior repurchases: $1.5B ASR in March 2026 and $22.4M open-market in Q3 2026.
- CEO states $4B returned to shareholders in ~2.5 years; ~42.9M shares outstanding as of Sept 4, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465926105953/0001104659-26-105953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465926105953/tm2624887d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-105953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer